| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 02/05/2013 | CA2411315C Method for detecting a detectable product |
| 02/05/2013 | CA2320359C Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (prrsv) |
| 02/05/2013 | CA2301199C A tumor suppressor designated ts10q23.3 |
| 02/05/2013 | CA2299119C A method of stabilizing and/or isolating nucleic acids |
| 02/02/2013 | WO2012014551A1 Detection device and detection method for intermolecular interaction |
| 01/31/2013 | WO2013016700A1 Methods for generating predictive models for epithelial ovarian cancer and methods for identifying eoc |
| 01/31/2013 | WO2013016613A1 Pentraxin 3 association with asthma |
| 01/31/2013 | WO2013016604A1 Method for assessing condition of fibers |
| 01/31/2013 | WO2013016600A2 Methods and reagents for diagnosing conditions and characterization of tumor cells associated with serous fluids |
| 01/31/2013 | WO2013016460A1 Compositions and methods for assessing functional immunogenicity of parvovirus vaccines |
| 01/31/2013 | WO2013016459A1 Breakage of an emulsion containing nucleic acid |
| 01/31/2013 | WO2013016454A1 Assays to monitor bleeding disorders |
| 01/31/2013 | WO2013016449A2 Assays for the detection of microbes |
| 01/31/2013 | WO2013016427A1 Methods and pharmaceutical compositions for treating celiac disease and gluten intolerance |
| 01/31/2013 | WO2013016425A2 Fecal neopterin concentration measurement as an indicator of disease activity in inflammatory bowel disease |
| 01/31/2013 | WO2013016419A1 Devices and methods for immobilizing nucleic acids |
| 01/31/2013 | WO2013016418A2 Ion channel probes and methods of use thereof |
| 01/31/2013 | WO2013016342A1 Methods for optimizing optical mapping conditions |
| 01/31/2013 | WO2013016279A1 Animal model of autism |
| 01/31/2013 | WO2013016152A1 Method for predicting haze in lubricant base stocks |
| 01/31/2013 | WO2013016114A2 Enzymatic cleavage based lateral flow assays |
| 01/31/2013 | WO2013016106A2 Glass sampling apparatus and method for using same to obtain a glass sample from a glass melting vessel |
| 01/31/2013 | WO2013015957A1 Estimating oil viscosity |
| 01/31/2013 | WO2013015822A1 Cartridge for diagnostic testing |
| 01/31/2013 | WO2013015781A1 Microchips and methods for testing a fluid sample |
| 01/31/2013 | WO2013015717A2 Method for determining the spatial and temporal distribution of the activity of a proteolytic enzyme in a heterogeneous system (variants), device for realizing same and method for diagnosing defects in the hemostatic system on the basis of a change in the spatial and temporal distribution of the activity of a proteolytic enzyme in a heterogeneous system |
| 01/31/2013 | WO2013015683A1 System and method for managing replacement of consumables including recyclable gas purifiers |
| 01/31/2013 | WO2013015483A1 Reader for urine analysis |
| 01/31/2013 | WO2013015367A1 Antibody for detecting epithelial ovarian cancer marker and method for diagnosing epithelial ovarian cancer |
| 01/31/2013 | WO2013015363A1 Antibody for detecting epithelial ovarian cancer marker and method for diagnosing epithelial ovarian cancer |
| 01/31/2013 | WO2013015331A1 Nash model animal |
| 01/31/2013 | WO2013015282A1 Method for measuring amount of analyte and device for spfs |
| 01/31/2013 | WO2013015089A1 Method for providing oncogenesis information and device for providing oncogenesis information |
| 01/31/2013 | WO2013014929A1 Method for screening induced pluripotent stem cells |
| 01/31/2013 | WO2013014843A1 Method for detecting target substance, sensor chip, and detection device |
| 01/31/2013 | WO2013014669A1 Lactoferrin fragments and use thereof |
| 01/31/2013 | WO2013014485A1 A2m fragments and applications thereof |
| 01/31/2013 | WO2013014474A1 Quantitative analysis of the basic components of wine, by correlation with measured physical parameters of wine |
| 01/31/2013 | WO2013014449A1 Assay for histidinyl hydroxylase activity |
| 01/31/2013 | WO2013014389A1 Microstructured adhesion substrate for animal or human cells |
| 01/31/2013 | WO2013014366A1 Extensometer for the blow analysis of the mechanical characteristics of a sample of a cereal-based dough |
| 01/31/2013 | WO2013014312A1 Chimeric polypeptides derived from the vimentin protein, suitable for use in the diagnosis of rheumatoid arthritis |
| 01/31/2013 | WO2013014287A2 Deuterium free, stable isotope labeled 2-phenylethylamine hallucinogens and/or stimulants, methods of their preparation and their use |
| 01/31/2013 | WO2013014286A2 Means and methods for diagnosing and monitoring heart failure in a subject |
| 01/31/2013 | WO2013014270A1 Method for determining the quality of non-crosslinked rubber mixtures, and corresponding device |
| 01/31/2013 | WO2013014244A1 Nik inhibitors cell-based screening assay |
| 01/31/2013 | WO2013014187A1 Device for measuring the free chloride content of water |
| 01/31/2013 | WO2013014184A1 Mt1-mmp substrates as biomarkers of inflammatory angiogenesis |
| 01/31/2013 | WO2013013922A1 Method for detecting biomolecules |
| 01/31/2013 | WO2013013864A1 Process for individualized hair treatment |
| 01/31/2013 | WO2013013758A1 Mid-regional pro-atrial natriuretic peptide (pro-anp) for the identification patients with atrial fibrillation with an onset of less than 48 hours ago |
| 01/31/2013 | WO2013013303A1 Ovarian markers of follicular maturity and uses thereof |
| 01/31/2013 | WO2013013302A1 Synthetic lethality and the treatment of cancer |
| 01/31/2013 | WO2013013268A1 Platelet assessment assays, diagnosis and kits therefor |
| 01/31/2013 | WO2013013253A1 Container unit for a substantially liquid sample |
| 01/31/2013 | WO2012170704A3 Methods and compositions of predicting activity of retinoid x receptor modulator |
| 01/31/2013 | WO2012154957A3 Diagnosis and prognosis of triple negative breast and ovarian cancer |
| 01/31/2013 | WO2012154794A3 Enzyme concentration and assays |
| 01/31/2013 | WO2012144859A9 Method and apparatus for analyzing protein-protein interaction on single-molecule level within the cellular environment |
| 01/31/2013 | WO2012142300A3 Methods of determining a treatment protocol for and/or a prognosis of a patient's recovery from a brain injury resulting from a hypoxic event |
| 01/31/2013 | WO2012129455A4 Microfluidic devices and methods of manufacture and use |
| 01/31/2013 | WO2012129408A3 Biomarkers for aggressive prostate cancer |
| 01/31/2013 | WO2012121913A3 Improved method for quantitative analysis of sugars, sugar alcohols and related dehydration products |
| 01/31/2013 | WO2012116229A4 Compositions and methods for personal tumor profiling treatment |
| 01/31/2013 | WO2012116181A3 Small molecules for endothelial cell activation |
| 01/31/2013 | WO2012116159A3 Device for and method of extracting a fraction from a biological sample |
| 01/31/2013 | WO2012112697A3 Method and system to digitize pathology specimens in a stepwise fashion for review |
| 01/31/2013 | WO2012110878A3 Method of diagnosing cancer and diagnosis kit using measurement of nk cell activity |
| 01/31/2013 | WO2012106514A3 System and method for diagnosis and treatment |
| 01/31/2013 | WO2012097207A3 Cytokine profiles as methods for diagnosis and prognosis of irritable bowel syndrome |
| 01/31/2013 | US20130031647 Humanized anti cxcr4 antibodies for the treatment of cancer |
| 01/31/2013 | US20130031646 Model system of acanthamoeba keratitis syndrome and method for selecting a treatment thereof |
| 01/31/2013 | US20130030714 Methods for the survey and genetic analysis of populations |
| 01/31/2013 | US20130030712 Methods for the survey and genetic analysis of populations |
| 01/31/2013 | US20130030059 T1r hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds |
| 01/31/2013 | US20130030035 Identification of micro-rnas involved in neuromuscular synapse maintenance and regeneration |
| 01/31/2013 | US20130029998 Method of Detecting and Profiling Progression of the Risk of Neurodegenerative Diseases |
| 01/31/2013 | US20130029955 Inhibitors of galectin-3 and methods of use thereof |
| 01/31/2013 | US20130029871 Methods of stratifying adolescent idiopathic scoliosis, isolated nucleic acid molecules for use in same and kits using same |
| 01/31/2013 | US20130029868 Methods and kits for the detection of cancer infiltration of the central nervous system |
| 01/31/2013 | US20130029865 Stromal Antigen 2 (STAG2) Compositions and Methods |
| 01/31/2013 | US20130029859 Biomarker assay of neurological condition |
| 01/31/2013 | US20130029856 Transfer Or Interrogation Of Materials By Carrier And Receiving Devices Moving Independently And Simultaneously On Multiple Axes |
| 01/31/2013 | US20130029852 Detecting and classifying copy number variation |
| 01/31/2013 | US20130029433 Process condition measuring device |
| 01/31/2013 | US20130029429 Method for avoiding influence of endogenous lipoprotein and reagent |
| 01/31/2013 | US20130029374 Method and measuring point for measuring at least one physical and/or chemical, process variable of a measured medium contained in a single use container |
| 01/31/2013 | US20130029367 Compositions and methods for monitoring breast cancer treatment |
| 01/31/2013 | US20130029363 Method for diagnosing malignant tumor |
| 01/31/2013 | US20130029362 Markers and assays for detection of neurotoxicity |
| 01/31/2013 | US20130029361 Disc-shaped analysis chip |
| 01/31/2013 | US20130029360 Dimeric core-shell nanostructure labeled with raman active molecule localized at interparticle junction, use thereof, and method for preparing the same |
| 01/31/2013 | US20130029359 Monoclonal antibodies and diagnostic uses thereof |
| 01/31/2013 | US20130029358 Immunodominant mhc dr52b restricted ny-eso-1 epitopes, mhc class ii monomers and multimers, and uses thereof |
| 01/31/2013 | US20130029357 Diagnostic marker for effect of anticancer agent |
| 01/31/2013 | US20130029354 Multiple separation device and method for separating cancer cells in blood using the device |
| 01/31/2013 | US20130029353 Autoantibody enhanced immunoassays and kits |
| 01/31/2013 | US20130029352 Methods for diagnosing and monitoring the progression of cancer |
| 01/31/2013 | US20130029351 A25 bacteriophage lysin |
| 01/31/2013 | US20130029350 Bi-stable oscillator |